ASX - By Stock
|
PER |
Re:
Will PER follow DXB on a similar journey ?
|
|
acress
|
26 |
5.3K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
26
|
5.3K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
acress
|
102 |
25K |
0 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
102
|
25K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
acress
|
102 |
25K |
6 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
102
|
25K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
acress
|
102 |
25K |
13 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
102
|
25K
|
13
|
|
ASX - By Stock
|
PER |
Re:
PER - Megathread
|
|
acress
|
326 |
102K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
326
|
102K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
General Discussions
|
|
acress
|
96 |
34K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
96
|
34K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
acress
|
92 |
34K |
10 |
26/01/24 |
26/01/24 |
ASX - By Stock
|
92
|
34K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
acress
|
92 |
34K |
0 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
92
|
34K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
acress
|
92 |
34K |
3 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
92
|
34K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
acress
|
92 |
34K |
4 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
92
|
34K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Let’s go
|
|
acress
|
92 |
34K |
0 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
92
|
34K
|
0
|
|
ASX - By Stock
|
PER |
Re:
James Garner AKA JG
|
|
acress
|
190 |
49K |
3 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
190
|
49K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Intention to launch Share Purchase Plan
|
|
acress
|
75 |
21K |
1 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
75
|
21K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: ARG-007 Phase 2 Clinical Trial Update
|
|
acress
|
7 |
3.0K |
1 |
19/07/23 |
19/07/23 |
ASX - By Stock
|
7
|
3.0K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
acress
|
158 |
44K |
6 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
44K
|
6
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
acress
|
3.5K |
1.0M |
4 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial
|
|
acress
|
34 |
12K |
0 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
34
|
12K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
acress
|
98 |
29K |
1 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
98
|
29K
|
1
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
acress
|
3.5K |
1.0M |
1 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
1
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
acress
|
1.0K |
304K |
0 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
1.0K
|
304K
|
0
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
acress
|
3.5K |
1.0M |
7 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
acress
|
3.5K |
1.0M |
0 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Dosing commenced in the ATL1102 toxicology study
|
|
acress
|
19 |
7.1K |
3 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
19
|
7.1K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Proposed issue of securities - ANP
|
|
acress
|
22 |
7.7K |
3 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
22
|
7.7K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Presentation at International Conference on DMD
|
|
acress
|
8 |
2.6K |
3 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
8
|
2.6K
|
3
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
acress
|
3.5K |
1.0M |
6 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Notification regarding unquoted securities - ANP
|
|
acress
|
5 |
2.5K |
3 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
5
|
2.5K
|
3
|
|
ASX - By Stock
|
PER |
Re:
EQUITY RESEARCH REPORT - WILSON dated 18 Jan 2022
|
|
acress
|
126 |
42K |
3 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
126
|
42K
|
3
|
|